Finding Providers

We found 3 providers with an interest in multiple sclerosis and who accept Molina Healthcare near Southfield, MI.

Dr. Evanthia Bernitsas, MD
Specializes in Neurology
29829 Telegraph Road; Suite 200
Southfield, MI

Dr. Evanthia Bernitsas is a neurologist. Clinical interests for Dr. Bernitsas include multiple sclerosis (MS). Her professional affiliations include Wayne State University Physician Group (WSUPG), Children's Hospital of Michigan, and Karmanos Cancer Center. Blue Cross/Blue Shield, Coventry, and United Healthcare Plans are among the insurance carriers that Dr. Bernitsas honors. Dr. Bernitsas (or staff) speaks the following languages: Greek and French.

Read more

Relevant Interests: , multiple sclerosis (MS)

All Interests: Multiple Sclerosis

Dr. Steven Russell Hinderer, MD
Specializes in Spinal Cord Injury Medicine, Neuromuscular Medicine, Electrodiagnostic Medicine
23800 W 10 Mile Road; Suite 193
Southfield, MI

Dr. Steven Hinderer's medical specialty is spinal cord injury medicine, neuromuscular medicine, and electrodiagnostic medicine. Areas of expertise for Dr. Hinderer include back pain, spinal cord injuries, and spasticity. He takes Blue Cross/Blue Shield, Coventry, and United Healthcare Plans, in addition to other insurance carriers. His education and training includes medical school at the University of Michigan Medical School and residency at a hospital affiliated with the University of Washington. His professional affiliations include Oakwood Hospital - Southshore, Henry Ford Wyandotte Hospital, and Oakwood Hospital - Wayne.

Read more

Relevant Interests: , multiple sclerosis (MS)

All Interests: Neck Pain, Musculoskeletal Problems, Back Pain, Brain Injury, Electromyography, Multiple Sclerosis, ... (Read more)

No Photo
Specializes in General Internal Medicine
29829 Telegraph Road; Suite 200
Southfield, MI

Ms. Christina Caon's area of specialization is general internal medicine. She is especially interested in multiple sclerosis (MS). Ms. Caon takes several insurance carriers, including Blue Cross/Blue Shield, Coventry, and United Healthcare Plans. She is professionally affiliated with Wayne State University Physician Group (WSUPG).

Read more

Relevant Interests: , multiple sclerosis (MS)

All Interests: Multiple Sclerosis



Medicare Patient Age

Medicare Patient Conditions

Medicare Patient Ethnicity

Additional Information


Foreign Language

Online Communication

Practice Affiliation




Medical School



Years Since Graduation

What is Multiple Sclerosis?

Multiple sclerosis (MS) is an autoimmune disease that attacks the protective covering of nerves, causing communication issues between the brain and other parts of the body. The cause of MS is unknown, but some factors may raise a person’s risk of developing it. For example, if your parent or sibling has MS, or you have another autoimmune disease like type 1 diabetes, you may be more predisposed to getting MS than others.

Symptoms of MS vary widely from person to person. Common ones are weakness in the arm or leg, lack of balance, stiff muscles, fatigue, dizziness, partial or total vision loss, slurred speech, and issues with bowel and bladder function. While there is no cure for MS, treatments focus on the following:

  • Reducing attacks, which occur when nerves become inflamed (or swollen), causing new symptoms to arise or existing ones to worsen. Drugs like corticosteroids lessen inflammation and may help prevent attacks or limit their occurrence.
  • Slowing the development of the disease. Immunomodulators are medications that alter the body’s immune response. They may minimize nerve damage brought on by MS and thus decrease the rate at which it progresses.
  • Easing symptoms. Physical therapy can help with leg weakness and improve balance. Medicines like muscle relaxants may be prescribed to reduce muscle stiffness.
Living with MS can be a challenge, but due to advancements in medicine over the past few decades, the quality of life of people with MS has increased. Although the average life expectancy of those who have the disease is about five years lower than the rest of the population, this difference seems to be at a gradual but steady decline.